{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:44:52Z","timestamp":1791902692013,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.jaci.2003.12.323","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T05:21:14Z","timestamp":1082956874000},"page":"771-775","source":"Crossref","is-referenced-by-count":147,"title":["Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma"],"prefix":"10.1016","volume":"113","author":[{"given":"Lucyna","family":"Mastalerz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzta","family":"Setkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2003.12.323_BIB1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2500\/108854190778879909","article-title":"Landmark commentary: history of aspirin intolerance","volume":"11","author":"Settipanne","year":"1990","journal-title":"Allergy Proc"},{"key":"10.1016\/j.jaci.2003.12.323_BIB2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin: clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2003.12.323_BIB3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2003.12.323_BIB5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","article-title":"Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients","volume":"1","author":"Szczeklik","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.jaci.2003.12.323_BIB7","series-title":"Novel inhibitors of leukotrienes","author":"Folco","year":"1999"},{"key":"10.1016\/j.jaci.2003.12.323_BIB8","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2003.12.323_BIB9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","article-title":"Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis","volume":"60","author":"Szczeklik","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB10","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0091-6749(03)80977-6","article-title":"Non-steroidial anti-inflammatory drugs (NSAID) sensitivity in chronic idiophatic urticaria CIU: selective involvement of cyclooxygenase 1 (COX-1) and overproduction of cysteinyl-leukotrienes","volume":"111","author":"Setkowicz","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archderm.139.12.1577","article-title":"Safety of cyclooxygenase II inhibitors and increased leukotriene synthesis in chronic idiophatic urticaria with sensitivity to non-steroidial anti-inflammatory drugs","volume":"139","author":"Zembowicz","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB12","first-page":"49","article-title":"Rofecoxib, a slelective high affinity COX-2 inhibitor has proved to be safe in urticaria\/angioedema associated with NSAID intolerance","volume":"56","author":"Berges-Gimeno","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2003.12.323_BIB13","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/S0091-6749(02)81546-9","article-title":"Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and\/or nonsteroidial anti-inflammatory drugs","volume":"109","author":"Pacor","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.12.323_BIB14","first-page":"88331","article-title":"Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidial anti-inflammatory drugs","author":"Nettis","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB15","first-page":"110","article-title":"How safe are COX-2 inhibitors in NSAID\u2013sensitive subjects with cutaneous reactions","volume":"15","author":"Sanchez-Borges","year":"2003","journal-title":"ACI Int"},{"key":"10.1016\/j.jaci.2003.12.323_BIB16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis: oral therapy with new retinoid","volume":"157","author":"Frederiksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaci.2003.12.323_BIB17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.1995.tb01079.x","article-title":"Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans","volume":"25","author":"Kumlin","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.12.323_BIB18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0378-4347(94)00100-6","article-title":"Determination of 9 \u03b1 11 \u03b2 \u2013 prostaglandin F2 in human urine and plasma by gas chromatography\u2013mass spectrometry","volume":"655","author":"Obata","year":"1994","journal-title":"J Chromatogr"},{"key":"10.1016\/j.jaci.2003.12.323_BIB19","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(05)64015-9","article-title":"Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma","volume":"350","author":"Sanak","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2003.12.323_BIB20","series-title":"Eicosanoids, aspirin and asthma","first-page":"317","article-title":"Leukotrienes and aspirin-sensitive asthma","author":"Nasser","year":"1998"},{"key":"10.1016\/j.jaci.2003.12.323_BIB21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9\u03b1,11\u03b2-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2133.1981.tb15306.x","article-title":"Recurrent urticaria: clinical investigation of 330 patients","volume":"104","author":"Juhlin","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB23","series-title":"Allergy. Principles and practice","first-page":"1225","article-title":"Sensitivity to aspirin and nonsteroidal anti inflammatory drugs","author":"Stevenson","year":"1998"},{"key":"10.1016\/j.jaci.2003.12.323_BIB24","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1034\/j.1398-9995.2002.23767.x","article-title":"Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients","volume":"57","author":"Di Lorenzo","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2003.12.323_BIB25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1046\/j.1365-2222.2001.01074.x","article-title":"Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripherial blood leucocytes in aspirin-induced asthmatic patients","volume":"31","author":"Celik","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.12.323_BIB26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1365-2222.2001.01189.x","article-title":"Efficacy of leukotriene receptor antagonist in chronic urticaria: a double-blind comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and\/or acetylsalicylic acid","volume":"31","author":"Pacor","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.12.323_BIB27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1067\/mai.2002.126676","article-title":"The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study","volume":"110","author":"Erbagci","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB28","series-title":"Mast cells and basophils","author":"Marone","year":"2000"},{"key":"10.1016\/j.jaci.2003.12.323_BIB29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","article-title":"Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria","volume":"328","author":"Hide","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2003.12.323_BIB30","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI118325","article-title":"Serum IgG autoantibodies directed against the \u03b1 chain of Fc\u03b5RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?","volume":"96","author":"Fiebiger","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2003.12.323_BIB31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","article-title":"Comparative studies of functional and binding assays for IgG anti-Fc\u03b5RI \u03b1 (\u03b1-subunit) in chronic urticaria","volume":"101","author":"Ferrer","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000048163","article-title":"Pathophysiology of chronic urticaria","volume":"127","author":"Greaves","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","article-title":"Chronic urticaria and angioedema","volume":"346","author":"Kaplan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2003.12.323_BIB34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1081-1206(10)62384-8","article-title":"Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs","volume":"88","author":"Asero","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB35","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1164\/ajrccm.152.6.8520733","article-title":"Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance","volume":"152","author":"Szczeklik","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2003.12.323_BIB36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/1523-1747.ep12531738","article-title":"Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin","volume":"80","author":"Soter","year":"1983","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1165\/ajrcmb.23.3.4051","article-title":"Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma","volume":"23","author":"Sanak","year":"2000","journal-title":"Am J Respir Cell Med Biol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mai.2000.107603","article-title":"5\u2032Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant phenotype in the United States","volume":"106","author":"Van Sambeek","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.323_BIB39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/thorax.58.5.417","article-title":"Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma","volume":"58","author":"Sayers","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2003.12.323_BIB40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/thorax.55.suppl_2.S28","article-title":"Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast","volume":"55","author":"Sampson","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2003.12.323_BIB41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00008571-200210000-00009","article-title":"Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma","volume":"12","author":"Asano","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jaci.2003.12.323_BIB42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(95)90409-3","article-title":"Bronchoprotective role for endogenous prostaglandin E2","volume":"345","author":"Pavord","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2003.12.323_BIB43","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)90799-8","article-title":"Prostaglandin E2 and aspirin-induced asthma","volume":"345","author":"Szczeklik","year":"1995","journal-title":"Lancet"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903031373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903031373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T01:59:09Z","timestamp":1549763949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674903031373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0091674903031373"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2003.12.323","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}